These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28884590

  • 1. Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes.
    Gonai M, Shigehisa A, Kigawa I, Kurasaki K, Chonan O, Matsuki T, Yoshida Y, Aida M, Hamano K, Terauchi Y.
    Benef Microbes; 2017 Oct 13; 8(5):705-716. PubMed ID: 28884590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C, Gallagher E, Horton F, Ellis RJ, Ijaz UZ, Wu H, Jaiyeola E, Diribe O, Duparc T, Cani PD, Gibson GR, Hinton P, Wright J, La Ragione R, Robertson MD.
    Br J Nutr; 2016 Dec 13; 116(11):1869-1877. PubMed ID: 27974055
    [Abstract] [Full Text] [Related]

  • 4. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
    Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, van Eijk HM, Venema K, Smidt H, Zoetendal EG, Dejong CHC, Lenaerts K, Blaak EE.
    Gastroenterology; 2017 Jul 13; 153(1):87-97.e3. PubMed ID: 28396144
    [Abstract] [Full Text] [Related]

  • 5. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
    Elison E, Vigsnaes LK, Rindom Krogsgaard L, Rasmussen J, Sørensen N, McConnell B, Hennet T, Sommer MO, Bytzer P.
    Br J Nutr; 2016 Oct 13; 116(8):1356-1368. PubMed ID: 27719686
    [Abstract] [Full Text] [Related]

  • 6. The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut.
    Arnold JW, Roach J, Fabela S, Moorfield E, Ding S, Blue E, Dagher S, Magness S, Tamayo R, Bruno-Barcena JM, Azcarate-Peril MA.
    Microbiome; 2021 Jan 28; 9(1):31. PubMed ID: 33509277
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of Combined Prebiotic Galacto-Oligosaccharides and Bifidobacterium breve-Derived Postbiotic on Gut Microbiota and HbA1c in Prediabetic Adults: A Double-Blind, Randomized, Placebo-Controlled Study.
    Beteri B, Barone M, Turroni S, Brigidi P, Tzortzis G, Vulevic J, Sekulic K, Motei DE, Costabile A.
    Nutrients; 2024 Jul 10; 16(14):. PubMed ID: 39064648
    [Abstract] [Full Text] [Related]

  • 12. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.
    Grimaldi R, Swann JR, Vulevic J, Gibson GR, Costabile A.
    Br J Nutr; 2016 Aug 10; 116(3):480-6. PubMed ID: 27267934
    [Abstract] [Full Text] [Related]

  • 13. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
    Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, Walter J.
    Microbiome; 2018 Jun 28; 6(1):121. PubMed ID: 29954454
    [Abstract] [Full Text] [Related]

  • 14. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
    Ho J, Reimer RA, Doulla M, Huang C.
    Trials; 2016 Jul 26; 17(1):347. PubMed ID: 27456494
    [Abstract] [Full Text] [Related]

  • 15. Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.
    Liu F, Li P, Chen M, Luo Y, Prabhakar M, Zheng H, He Y, Qi Q, Long H, Zhang Y, Sheng H, Zhou H.
    Sci Rep; 2017 Sep 18; 7(1):11789. PubMed ID: 28924143
    [Abstract] [Full Text] [Related]

  • 16. A double-blind intervention trial in healthy women demonstrates the beneficial impact on Bifidobacterium with low dosages of prebiotic galacto-oligosaccharides.
    Looijesteijn E, Schoemaker MH, van den Belt M, Hester ER, Kortman GAM, Viskaal-van Dongen M, Nauta A.
    Front Nutr; 2024 Sep 18; 11():1440319. PubMed ID: 39224188
    [Abstract] [Full Text] [Related]

  • 17. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis.
    Yang XD, Wang LK, Wu HY, Jiao L.
    BMC Anesthesiol; 2018 Nov 30; 18(1):177. PubMed ID: 30497394
    [Abstract] [Full Text] [Related]

  • 18. The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions.
    Alizadeh A, Akbari P, Difilippo E, Schols HA, Ulfman LH, Schoterman MH, Garssen J, Fink-Gremmels J, Braber S.
    Br J Nutr; 2016 Feb 28; 115(4):605-18. PubMed ID: 26653138
    [Abstract] [Full Text] [Related]

  • 19. Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice.
    Cheng W, Lu J, Lin W, Wei X, Li H, Zhao X, Jiang A, Yuan J.
    Food Funct; 2018 Mar 01; 9(3):1612-1620. PubMed ID: 29465126
    [Abstract] [Full Text] [Related]

  • 20. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR, Kang SY, Kim SE, Lee SJ, Lee YC, Sung MK.
    World J Gastroenterol; 2019 Oct 28; 25(40):6129-6144. PubMed ID: 31686768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.